Skip to main content
eScholarship
Open Access Publications from the University of California

Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers.

  • Author(s): Meeter, Lieke HH
  • Gendron, Tania F
  • Sias, Ana C
  • Jiskoot, Lize C
  • Russo, Silvia P
  • Donker Kaat, Laura
  • Papma, Janne M
  • Panman, Jessica L
  • van der Ende, Emma L
  • Dopper, Elise G
  • Franzen, Sanne
  • Graff, Caroline
  • Boxer, Adam L
  • Rosen, Howard J
  • Sanchez-Valle, Raquel
  • Galimberti, Daniela
  • Pijnenburg, Yolande AL
  • Benussi, Luisa
  • Ghidoni, Roberta
  • Borroni, Barbara
  • Laforce, Robert
  • Del Campo, Marta
  • Teunissen, Charlotte E
  • van Minkelen, Rick
  • Rojas, Julio C
  • Coppola, Giovanni
  • Geschwind, Dan H
  • Rademakers, Rosa
  • Karydas, Anna M
  • Öijerstedt, Linn
  • Scarpini, Elio
  • Binetti, Giuliano
  • Padovani, Alessandro
  • Cash, David M
  • Dick, Katrina M
  • Bocchetta, Martina
  • Miller, Bruce L
  • Rohrer, Jonathan D
  • Petrucelli, Leonard
  • van Swieten, John C
  • Lee, Suzee E
  • et al.

Published Web Location

https://doi.org/10.1002/acn3.559
Abstract

Objective:To evaluate poly(GP), a dipeptide repeat protein, and neurofilament light chain (NfL) as biomarkers in presymptomatic C9orf72 repeat expansion carriers and patients with C9orf72-associated frontotemporal dementia. Additionally, to investigate the relationship of poly(GP) with indicators of neurodegeneration as measured by NfL and grey matter volume. Methods:We measured poly(GP) and NfL levels in cerebrospinal fluid (CSF) from 25 presymptomatic C9orf72 expansion carriers, 64 symptomatic expansion carriers with dementia, and 12 noncarriers. We explored associations with grey matter volumes using region of interest and voxel-wise analyses. Results:Poly(GP) was present in C9orf72 expansion carriers and absent in noncarriers (specificity 100%, sensitivity 97%). Presymptomatic carriers had lower poly(GP) levels than symptomatic carriers. NfL levels were higher in symptomatic carriers than in presymptomatic carriers and healthy noncarriers. NfL was highest in patients with concomitant motor neuron disease, and correlated with disease severity and survival. Associations between poly(GP) levels and small grey matter regions emerged but did not survive multiple comparison correction, while higher NfL levels were associated with atrophy in frontotemporoparietal cortices and the thalamus. Interpretation:This study of C9orf72 expansion carriers reveals that: (1) poly(GP) levels discriminate presymptomatic and symptomatic expansion carriers from noncarriers, but are not associated with indicators of neurodegeneration; and (2) NfL levels are associated with grey matter atrophy, disease severity, and shorter survival. Together, poly(GP) and NfL show promise as complementary biomarkers for clinical trials for C9orf72-associated frontotemporal dementia, with poly(GP) as a potential marker for target engagement and NfL as a marker of disease activity and progression.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View